Prevalence and Incidence of Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency

Ophanet, who are a consortium of European partners, currently defines a condition rare when if affects 1 person per 2,000. They list Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency as a "rare disease". More information about Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency is available from Orphanet

About prevalence and incidence statistics:

The term 'prevalence' of Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency usually refers to the estimated population of people who are managing Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency at any given time. The term 'incidence' of Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency refers to the annual diagnosis rate, or the number of new cases of Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency diagnosed each year. Hence, these two statistics types can differ: a short-lived disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics.

Search Specialists by State and City